Fachbücher

Beiträge in Fachzeitschriften und Fachbüchern 2017

  • Dathe K, Padberg S, Hultzsch S, Köhler LM, Meixner K, Fietz AK, Tissen-Diabaté T, Meister R, Schaefer C. Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study. Eur J Clin Pharmacol 2017 Dec 7. doi: 10.1007/s00228-017-2385-1.
  • Dathe K, Schaefer C. Drug safety in pregnancy: the German Embryotox institute. Eur J Clin Pharmacol. 2017 Oct 24. doi: 10.1007/s00228-017-2351-y.
  • Schaefer C, Dorsch V, Rohde A. Psychopharmakotherapie und psychiatrische Begleitung in Schwangerschaft und Stillzeit. In: Möller, Laux, Kapfhammer (Hrg.): Psychiatrie Psychosomatik Psychotherapie, 5. Aufl. Springer, Heidelberg 2017.
  • Schaefer C. Autismus beim Kind durch Antidepressiva? (Rezension) InFo Neurologie & Psychiatrie 2017; 19 (10).
  • Dathe K, Padberg S, Hultzsch S, Meixner K, Tissen-Diabaté T, Meister R, Beck E, Schaefer C. Metamizole use during first trimester - A prospective observational cohort study on pregnancy outcome. Pharmacoepidemiol Drug Saf 2017 August 3. DOI: 10.1002/pds.4277.
  • Spielmann K, Kayser A, Beck E, Meister R, Schaefer C. Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study. Cephalalgia 2017. doi: 10.1177/0333102417724152.
  • Padberg S, Mick I, Frenzel C, Greil R, Hilberath J, Schaefer C. Transient congenital dilated cardiomyopathy under R-CHOP chemotherapy during pregnancy. Reprod Toxicol 2017; 71:146-149.
  • Hoeltzenbein M, Beck E, Fietz AK, Wernicke J, Zinke S, Kayser A, Padberg S, Weber-Schoendorfer C, Meister R, Schaefer C. Pregnancy outcome after first trimester use of methyldopa: A prospective cohort study. Hypertension 2017; 70: 201-8.
  • Weber-Schoendorfer C, Beck E, Tissen-Diabaté T, Schaefer C. Leflunomide - a human teratogen? A still not answered question. An evaluation of the German Embryotox pharmacovigilance database. Reprod Toxicol 2017; 71: 101-7.
  • Østensen M, Hoeltzenbein M. Medikamente in der Schwangerschaft. In: Fischer-Betz R, Østensen M (Hrsg.) Rheumatische Erkrankungen in der Schwangerschaft. De Gruyters, 2017, S. 173-203.
  • Hüttel E, Padberg S, Meister R, Beck E, Schaefer C. Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment. Thromb Haemost 2017; 117: 870-9.
  • Beck E, Lechner A, Schaefer C. Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy. Reprod Toxicol 2017; 67:79-87.

Beiträge in Fachzeitschriften und Fachbüchern 2016

  • Diav-Citrin O, Shechtman S, Arnon J, Wajnberg R, Borisch C, Beck E et al. Methylphenidate in pregnancy: A multicenter, prospective, comparative, observational study. J Clin Psychiatry 2016; 77:1176-81.
  • Kayser A, Schaefer C. Medikamentöse Therapie bei Schwangerschaft oder Kinderwunsch. Gynäkologische Endokrinologie 2016 doi:10.1007/s10304-016-0102-2.
  • Richardson JL, Stephens S, Yates LM, Diav-Citrin O, Arnon J, Beghin D, Kayser A et al. Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services. Reprod Toxicol 2016 http://dx.doi.org/10.1016/j.reprotox.2016.11.010.
  • Hultzsch S, Schaefer C. Schmerzmedikation in der Schwangerschaft. Schmerz 2016, November 2  [Epub ahead of print].doi:10.1007/s00482-016-0167-9.
  • Dathe K, Beck E, Schaefer C. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database. Reprod Toxicol 2016; 65: 39-45.
  • Hultzsch S. Schmerztherapie in der Schwangerschaft. In: Eckart et al. (Hrg): Anästhesiologie, Kompendium und Repetitorium zur Weiter- und Fortbildung, 49. Aktualisierung 9/2016, ecomed Medizin, Landsberg /Lech.
  • Hoeltzenbein M, Beck E, Rajwanshi R, Götestam Skorpen C, Berber E, Schaefer C, Østensen M. Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data. Seminars Arthritis Rheumatism 2016 May 27 [Epub ahead of print].
  • Weber-Schoendorfer C, Beck E, Schaefer C. Pregnancy outcomes in women who have taken leflunomide before or during pregnancy – a prospective case series from the German Embryotox center (Abstract). Reprod Toxicol 2016; 60: 186.
  • Hoeltzenbein M, Beck E, Rajwanshi R, Skorpen CG, Berber E, Schaefer C, Østensen M. Tocilizumab use in pregnancy: Analysis of a Global Safety Database including data from clinical trials and post-marketing data (Abstract).  Reprod Toxicol 2016; 60: 173.
  • Dathe K, Beck E, Schaefer C. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox database (Abstract).  Reprod Toxicol 2016; 60: 178.
  • Hüttel E, Beck E, Meister R, Schaefer C. Risk increase of spontaneous abortion with maternal phenprocoumon therapy depends on time of treatment discontinuation during first trimester (Abstract).  Reprod Toxicol 2016; 60: 174.
  • Beck E, Lechner A, Schaefer C. Who seeks teratology information service’s advice? A Germany-based evaluation of representativeness by socioeconomic indicators (Abstract). Reprod Toxicol 2016; 60: 172.
  • Hoeltzenbein M, Beck E, Rajwanshi R, Skorpen CG, Berber E, Schaefer C, Østensen M. Tocilizumab use in pregnancy: Analysis of a Global Safety Database including data from clinical trials and post-marketing data (Abstract).  Pharmacoepidemiol Drug Saf 2016; 25 (Suppl. 3): 323.
  • Douros A, Schaefer C, Kreutz R, Garbe E. Pharmakovigilanz in Deutschland - Es wird langsam Zeit. Internist 2016 May 25. [Epub ahead of print]
  • Götestam Skorpen C, Hoeltzenbein M et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016; 75: 795-810.
  • Bérard A, Wisner KL, Hultzsch S, Chambers C. Field studies versus database studies on the risks and benefits of medication use during pregnancy: Distinct pieces of the same puzzle. Reprod Toxicol 2016; 60: 123-28.
  • Weber-Schoendorfer C, Schaefer C. Pregnancy outcome after tocilizumab therapy in early pregnancy - a case series from the German Embryotox Pharmacovigilance Center. Reprod Toxicol 2016; 60: 29-32.
  • Hoeltzenbein M, Wacker E, Meixner K, Schaefer C, Kreutz R. Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban: A case series from the German Embryotox Pharmacogivilance Centre. Clin Res Cardiol 2016; 105: 117-26.

Beiträge in Fachzeitschriften und Fachbüchern 2015

  • Scherneck S, Schöpa FL, Entezami M, Kayser A, Weber-Schoendorfer C, Schaefer C. Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure. Reprod Toxicol 2015; 58: 61-64.
  • Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N; network of French pharmacovigilance centres, Beghin D, Cuppers-Maarschalkerweerd B, Richardson JL, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Kadioglu Duman M, Meister R, Schaefer C. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol 2015; 80:727-39.
  • Paulzen M, Gründer G, Orlikowsky T, Gräf CM, Hoeltzenbein M et al. Suicide Attempt During Late Pregnancy With Quetiapine: Nonfatal Outcome Despite Severe Intoxication. J Clin Psychopharmacol 2015; 35: 343-4.
  • Solecki R, Rauch M, Gall A, Buschmann J, Clark R, Fuchs A, Kan H, Heinrich V, Kellner R, Knudsen TB, Li W, Makris SL, Ooshima Y, Paumgartten F, Piersma AH, Schönfelder G, Oelgeschläger M, Schaefer C, Shiota K, Ulbrich B, Ding X, Chahoud I. Continuing harmonization of terminology and innovations for methodologies in developmental toxicology: Report of the 8th Berlin Workshop on Developmental Toxicity, 14-16 May 2014. Reprod Toxicol 2015 [Epub June 11].
  • Oppermann M, Borisch C, Schaefer C. Hip arthroplasty with high chromium and cobalt blood levels –€œ Case report of a patient followed during pregnancy and lactation period. Reprod Toxicol 2015; 53: 51-53.
  • Wacker E, Navarro A, Meister R, Padberg S, Weber-Schoendorfer C, Schaefer C. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome. Pharmacoepidemiol Drug Saf 2015; 24: 353-60.
  • Nijhof S, Kutz PI, Schulze R, Schaefer C et al. Konnataler intermittierender AV-Block III° nach Retinoideinnahme in der Schwangerschaft. Z Geburtsh Neonatol 2015; 219: 1–€œ4.
  • Schaefer C. Besonderer Beratungsbedarf bei psychischen Erkrankungen: Embryotox und das Dilemma mit Medikamenten in der Schwangerschaft; in Rohde A (Hrg). Frauen-Leid und Frauen-Stärkung - Im Fokus von Gynäkologischer Psychosomatik und Gynäkopsychiatrie. Psychiatrie-Verlag, Köln 2015.
  • Oppermann M, Schaefer C. Fetotoxisches Risiko der AT1-Antagonisten and ACE-Hemmer. Bulletin zur Arzneimittelsicherheit (BfArM, Paul-Ehrlich-Institut) 2015; 1: 8-11.

Beiträge in Fachzeitschriften und Fachbüchern 2014

Beiträge in Fachzeitschriften und Fachbüchern 2013

Beiträge in Fachzeitschriften und Fachbüchern 2012

  • Fritzsche J, Pilch A, Mury D, Schaefer C, Weber-Schoendorfer C. Infliximab and Adalimumab Use During Breastfeeding. J Clin Gastroenterol 2012; 46 (8): 718-9.
  • Borisch C, Kayser A, Weber-Schoendorfer C, Schaefer C. Severe neutropenia in a newborn after clozapine therapy during pregnancy (Abstract). Reprod Toxicol 2012; 34: 158.
  • Schaefer C, Weber-Schöndorfer C. Aktuelle Aspekte zum Arzneimitteleinsatz in Schwangerschaft und Stillzeit. Arzneimitteltherapie 2012; 30: 383-90.
  • Schaefer C,  Oppermann M, Wacker E, Weber-Schoenfelder C. Arzneimitteltherapiesicherheit in der Schwangerschaft –€œ das Embryotox-Projekt. ZEFQ 2012; 106: 723-8.
  • Artmann T, Hönig A, Wirbelauer J, Schaefer C, Schelling P, Kranke P. Stillen nach Narkosen: Ist eine Stillpause obligat? Geburtsh Frauenheilk 2012; 72, 983-987.
  • Bar-Oz B, Weber-Schoendorfer C, Berlin M et al. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study. Drug Saf 2012; 35 :589-98.
  • Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, Schaefer C. A-(H1N1)v 2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012; 30: 4445-52.
  • Fritzsche J, Borisch C, Schaefer C. Case Report: High Chromium and Cobalt Levels in a Pregnant Patient with Bilateral Metal-on-Metal Hip Arthroplasties. Clin Orthop Relat Res 2012; 470:2325-31. Erratum: Clin Orthop Relat Res 2012; 470: 2626.
  • Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, Allignol A, Weber-Schoendorfer C, Schaefer C. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A 2012; 158A: 588-96.
  • Schaefer C, Hoffmann-Walbeck P. Intoxikationen bei Schwangeren. Med Klin Intensivmed Notfmed 2012; 107: 118-22.
  • Tümmler G, Schaefer C. Duogynon: Angeborene Fehlbildungen nach Applikation der Östrogen-Progesteron-Kombination in der Schwangerschaft –€œ Auswertung einer retrospektiven Fallserie. Bulletin zur Arzneimittelsicherheit (BfArM, Paul-Ehrlich-Institut) 2012; 4: 20-23.
  • Rohde A, Dorsch VM, Schaefer C. Die Behandlung mit Psychopharmaka in der Schwangerschaft –€œ So wenig wie möglich, aber so viel wie nötig. Fortschr Neurol Psychiatr 2012; 80: 227-40.
  • Reuvers  N, Vial T, Schaefer C et al. Pregnancy outcome after first trimester exposure to malarone (atovaquone-proguanil): a prospective case-series (Abstract). Birth Defects Research A 2012; 94: 329
  • Hoeltzenbein M, Weber-Schoendorfer C, Borisch C, Allignol A, Meister R, Schaefer C. Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine. Reprod Toxicol 2012; 34: 364-9.
  • Schaefer C. Arzneimittelsicherheit in der Schwangerschaft –€œ eine Utopie? Geburtsh Frauenheilk 2012; 72: 701-2.
  • Schaefer C, Weber-Schoendorfer C. Aktuelle Aspekte zum Arzneimitteleinsatz in Schwangerschaft und Stillzeit. Krankenhauspharmazie 2012; 33: 347-55.
  • Schaefer C. Paradigm change in pain therapy: Do we take leave of paracetamol in pregnancy? (Abstract) Reprod Toxicol 2012; 34: 150.
  • Panchaud A, Csajka C, Merlob P, Schaefer C et al. Pregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospective Study. J Clin Pharmacol J Clin Pharmacol. 2012 Dec;52(12):1844-51.

Beiträge in Fachzeitschriften und Fachbüchern 2011

  • Weber-Schoendorfer C, Fritzsche J, Schaefer C. Pregnancy outcomes in women exposed to adalimumab or infliximab. The Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy (Abstract). Reprod Toxicol 2011; 31: 267-8.
  • Hoeltzenbein M, Supcun-Ritzler S, Langthaler M, Daumer-Haas C, Schaefer C. Lacosamide during pregnancy: Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy (Abstract). Reprod Toxicol 2011; 31: 259.
  • Oppermann M, Padberg S, Schaefer C. Angiotensin II-receptor 1-antagonists during 2nd or 3rd trimester: Evaluation of a case series from the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy (Abstract). Reprod Toxicol 2011; 31: 264.
  • Hultzsch S, Weber-Schoendorfer, Schaefer C. Pregnancy outcomes after exposure to etanercept (Abstract). Reprod Toxicol 2011; 31: 260.
  • Fritzsche J, Mury D, Wintgens KF Pilch A, Schaefer C, Weber-Schoendorfer C. Infliximab and adalimumab use during lactation (Abstract). Reprod Toxicol 2011; 31: 258.
  • Schaefer C. Drug Safety in Pregnancy –€œ Utopia or achievable prospect? Risk information, risk research, advocacy in Teratology Information Services. Congenit Anom 2011; 51: 6-11.
  • Schaefer C, Wieacker P. Teratogene Faktoren. In Murken J, Grimm T, Holinski-Feder (Hrg): Humangenetik, 8. Aufl. Thieme-Verlag 2011.
  • Kranke P, Frambach T, Schelling Ph, Wirbelauer J, Schaefer C, Stamer U. Stillen nach Narkosen: Ist eine Stillpause obligat? Anasthesiol Intensivmed Notfallmed Schmerzther 2011; 46: 304-11.
  • Schaefer C, Sartane und ACE-Hemmer schaden dem Feten, Frauenarzt 2011; 52:2-3.
  • Regitz-Zagrosek V, Seeland U, Geibel-Zehender A, Gohlke-Bärwolf C, Kruck I, Schaefer C. Herz-Kreislauf-Erkrankungen in der Schwangerschaft. Dtsch Ärztebl 2011;108:267-73.

Beiträge in Fachzeitschriften und Fachbüchern 2010

  • Hoeltzenbein M, Elefant E, Garayt C, Ornoy A, Clementi M, Manakova E, Merlob P, Rodríguez-Pinilla E,  Rothuizen L, Smorlesi C, te Winkel B, de Santis M, Stephens S, Vial T, Weber-Schoendorfer C, Schaefer C. Maternal exposure to mycophenolate mofetil in pregnancy –€œ Results of the ENTIS collaborative study (Abstract). Reprod Toxicol 2010; 30: 228
  • Habermann F, Karbaum F, Meister R, Weber-Schoendorfer C, Schaefer C. Pregnancy outcome after exposure to second-generation antipsychotics (Abstract). Reprod Toxicol 2010; 30: 228.
  • Fritzsche J, Borisch C, Weber-Schoendorfer C, Schaefer C. High levels of chromium and cobalt in a pregnant patient with metal-on-metal hip arthroplasty (Abstract). Reprod Toxicol 2010; 30: 237-8.
  • Dostal M, Felberg M, Weber-Schoendorfer C, Schaefer C. Treatment of restless legs syndrome during pregnancy (Abstract). Reprod Toxicol 2010;30:236-7.
  • Schaefer C , Fritzsche J, Karbaum  F, Allignol A, Meister R, Weber-Schoendorfer C. 2009 H1N1 Vaccination in Pregnancy –€œ Experience of the European Network of Teratology Information Services (ENTIS) (Abstract). Reprod Toxicol 2010; 30: 220.
  • Rohde A, Schaefer C. Psychopharmakotherapie und psychiatrische Begleitung in Schwangerschaft und Stillzeit. In: Möller, Laux, Kapfhammer (Hrg.): Psychiatrie und Psychotherapie, 4. Aufl. Springer, Heidelberg 2010.
  • Schaefer C. Risiken der Sartantherapie in der Schwangerschaft. Monatsschr Kinderheilk 2010; 12: 5.
  • Hoyer AC, Henrich W, Schaefer C, Spors B, Czernik C. Coumarin Embryopathy after intrauterine exposure to Vitamin K antagonists within the first 10 post-menstrual weeks. Ultraschall in Med 2010; 31: 411–€œ413
  • Hoeltzenbein M, Weber-Schoendorfer C, Padberg S, Borisch C, Schaefer C. Paternal exposure to azathioprine/6-mercaptopurine - Experience of Berlin TIS (Abstract). Reprod Toxicol 2010; 30: 238-9. Poster präsentiert auf der ENTIS-Konferenz 2010 in Barcelona.
  • Rabe T, Ludwig M, Goeckenjan M, Schaefer C. Was bei Langzeitkontrazeption post partum zu beachten ist. Gyne 2010; 1: 19-22.
  • Schaefer C, Meister R, Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome- an observational study of the Berlin Institute for Clinical teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet 2010; 281: 221-7.
  • Henze T, Janzen R, Schumm F, Melms A, Sieb J, Köhler W, Heidenreich F, Tackenberg B, Weber-Schöndorfer C. Immuntherapie bei Myasthenia gravis und Lambert-Eaton Syndrom. Teil 1: Medikamentöse Immunsuppression. Akt Neurol 2010;37 (10):505-517.
  • Nickerson ML, Kostiha BN, Brandt W, Fredericks W, Xu KP, Yu FS, Gold B, Chodosh J, Goldberg M, Lu da W, Yamada M, Tervo TM, Grutzmacher R, Croasdale C, Hoeltzenbein M et al. UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One. 2010 May 21;5(5):e10760.
  • Chen W, Ullmann R, Langnick C, Menzel C, Wotschofsky Z, Hu H, Döring A, Hu Y, Kang H, Tzschach A, Hoeltzenbein M et al. Breakpoint analysis of balanced chromosome rearrangements by next-generation paired-end sequencing. Eur J Hum Genet. 2010; 18: 539-43.

Beiträge in Fachzeitschriften und Fachbüchern 2009

  • Rabe T, Ludwig M, Goeckenjan M, Schaefer C. Methoden der Kontrazeption im Wochenbett und Anwendungseinschränkungen bei stillenden Frauen. Gyne 2009; 12: 19-23.
  • Schaefer C, Rohde A. So wenig wie möglich, soviel wie nötig. ÄP Neurologie Psychiatrie 2009; 11: 24-7.
  • Weber-Schoendorfer C, Schaefer C. Multiple Sclerosis, immunomodulators and pregnancy outcome. A prospective observational study. Mult Scler 2009 15:1037-42.
  • Schaefer C, Meister R, Wentzeck R, Weber-Schoendorfer C. Fetal outcome after technetium scintigraphy in early pregnancy. Reprod Toxicol 2009; 28: 161-166.
  • Schaefer C, Weber-Schoendorfer C. Pharmakotherapie in der Schwangerschaft, CME Weiterbildung. Internist 2009; 50: 455-66.
  • Becker C, Stichtenoth D, Wichmann M, Schaefer C, Szinicz L. Blood donors on medication. An approach to minimize drug burden for recipients of blood products and to limit deferral of donors. Transfus Med Hemother 2009; 36: 107-13.
  • Hoeltzenbein M, Weber-Schoendorfer C, Schaefer C. Mycophenolate mofetil –€œ a teratogenic drug? Experience of the Berlin Institute of Clinical teratology and drug risk assessment during pregnancy (Abstract). Medizinische Genetik 2009; 21: 78-9.
  • Schaefer C. Topische und systemische Therapie in der Schwangerschaft (Abstract). JDDG 2009; 7 (Suppl. 4): 43.
  • Jürgens T, Schaefer C, May A. Treatment of cluster headache in pregnancy and lactation. Cephalalgia 2009; 29:391-400.
  • Schaefer C. Arzneimittel in der Schwangerschaft und Stillperiode. In: Reiss M (Hrg): Facharztwissen HNO. Springer, Heidelberg 2009.
  • Schaefer C. Arzneitherapie in Schwangerschaft und Stillzeit. In Arzneimittelkommission der deutschen Ärzteschaft (Hrg): Arzneiverordnungen, 22. Aufl. MMI, Neu-Isenburg 2009.
  • Rabe T, Ludwig M, Goeckenjan M, Schaefer C. Welche Verhütung ist im Anschluss an eine Geburt und in der Stillzeit effektiv? Gyne 2009; 8: 19-21.
  • Gueneau L, Bertrand AT, Jais JP, Salih MA, Stojkovic T, Wehnert M, Hoeltzenbein M et al. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet. 2009 Sep;85(3):338-53.
  • Neumann TE, Allanson J, Kavamura I, Kerr B, Neri G, Noonan J, Cordeddu V, Gibson K, Tzschach A, Krüger G, Hoeltzenbein M et al. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome. Eur J Hum Genet. 2009 Apr;17(4):420-5.
  • Tzschach A, Ramel C, Kron A, Seipel B, Wüster C, Cordes U, Liehr T, Hoeltzenbein M et al. Hypergonadotropic hypogonadism in a patient with inv ins (2;4). Int J Androl. 2009 Jun;32(3):226-30.

Beiträge in Fachzeitschriften und Fachbüchern 2008

  • Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C. The safety of calcium channel blockers during pregnancy. A prospective, multicenter, observational study. Reprod Toxicol 2008; 26: 24-30. 
  • Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome - Methodological considerations. Reprod Toxicol 2008; 26: 36-41.
  • Meister R, Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies. –€œ Analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol 2008; 26: 31-35.
  • Weber-Schoendorfer C, Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study. Reprod Toxicol 2008; 26: 19-23.
  • Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Arnon J, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C & Ornoy A. Paroxetine and Fluoxetine in Pregnancy: a prospective, multi-center, controlled, observational study. Br J Clin Pharmacol 2008; 65: 695-705.
  • Rohde A, Schaefer C. Betreuung schwangerer und stillender Patientinnen –€œ Psychopharmakotherapie und psychiatrische Begleitung. In: Möller, Laux, Kapfhammer (Hrg.): Psychiatrie und Psychotherapie, 3. Aufl. S. 1235-44. Springer, Heidelberg 2008.
  • Weber-Schoendorfer C, Schaefer C. [Trastuzumab in pregnancy] Letter to the Editor. Reprod Toxicol 2008; 25: 390-1.
  • Panchaud A, Stahl B, Schaefer C, Berlin M, De Santis M, Vial T, Ieri A, Malm H, Eleftheriou G, Buclin T. Topical retinoids exposure during the first trimester of pregnancy (Abstract). Posterpräsentation. World Conference on Clinical Pharmacology and Therapeutics. Quebec, Canada 2008.
  • Schaefer C50 Jahre nach Contergan - Eine Betrachtung zur Arzneimittelsicherheit in der Schwangerschaft heute. Arzneiverordnung in der Praxis 2008; 35: 65-6.
  • Hoeltzenbein M, Weber-Schoendorfer C, von Stackelberg L, Schaefer C. Paternal exposure to drugs –€œ Is there an increased risk for congenital abnormalities? Experience of the Berlin Institute of Clinical Teratology and Drug Risk Assessment during Pregnancy (Abstract). Med Genetik 2008; 20: 166.
  • Rabe T, Ludwig M, Bitzer J, Geisthövel F, Schaefer C. Schwangerschaften unter verschiedenen kontrazeptiven Methoden. J Reproduktionsmed Endokrinol 2008; 5: 138-146.
  • Rabe T, Ludwig M, Bitzer J, Geisthövel F, Schaefer C. Terato- bzw. Mutagenität von Arzneimitteln: Wenn unter Anwendung von Kontrazeptiva eine Schwangerschaft eintritt (zertifizierte Fortbildung). Gyne 2008; 5: 1-8.
  • Padberg S, Weber-Schoendorfer C, Schaefer C. Lamotrigine during lactation (Abstract). Reprod Toxicol 2008; 26: 70/71.
  • Weber-Schoendorfer C, Schaefer C. Monoclonal antibody therapy during pregnancy –€œ Experience of the Berlin Teratology Information Service (Abstract). Reprod Toxicol 2008; 26: 75.
  • Weber-Schoendorfer C, Schaefer C. Multiple sclerosis –€œ effects of immunomodulatory therapy on pregnancy outcome: An observational study of the Teratology Information Service Berlin, Germany (Abstract). Birth Def Res A 2008; 82: 298.
  • Hoeltzenbein M, Weber-Schoendorfer C, v. Stackelberg L, Schaefer C. Paternal exposure to drugs –€œ Is there an increased risk for congenital abnormalities? Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment during Pregnancy (Abstract). Reprod Toxicol 2008; 26: 64.
  • Møller RS, Kübart S, Hoeltzenbein M et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet. 2008 May;82(5):1165-70.

Beiträge in Fachzeitschriften und Fachbüchern 2007

  • Goldstein LH, Dolinsky G, Greenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrin  O, Malm H, Reuvers-Lodewijks ME, Rost van Tonningen-van Driel MM, Arnon J, Ornoy A, Clementi M, Di Gianantonio E, Koren G, Braunstein R, Berkovitch M. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Research A 2007; 79: 696-701.
  • Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C, Stojanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S. Colchicine use in children and adolescents with Familial Mediterranean fever. Literature review and consensus statement. Pediatrics 2007; 119: e474-83.
  • Schaefer C. Off-label-Use von Medikamenten in der Schwangerschaft. Der Frauenarzt 2007; 48: 20-5.
  • Meister R, Schaefer C. Spontaneous abortion rates: Unbiased statistical estimation – with coumarins as an example (Abstract). Reprod Toxicol 2007; 24: 64.

Beiträge in Fachzeitschriften und Fachbüchern 2006 und älter (Auswahl)